Characterization of an imatinib-sensitive subset of high-grade human glioma cultures
Data up to Jan 2025
Total Citations Per Year
Abstract
References (33)
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 • 11,586 citations
In silico prediction of protein-protein interactions in human macrophages
2014 • 11,120 citations
Significance analysis of microarrays applied to the ionizing radiation response
2001 • 10,393 citations
Identification of human brain tumour initiating cells
2004 • 7,166 citations
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 • 5,189 citations
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
2002 • 4,254 citations
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
2004 • 2,521 citations
The WHO Classification of Tumors of the Nervous System
2002 • 1,931 citations
Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin
1985 • 1,523 citations
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
2005 • 1,418 citations
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
2002 • 1,349 citations
Amplified RNA synthesized from limited quantities of heterogeneous cDNA.
1990 • 1,258 citations
Genetic Pathways to Glioblastoma
2004 • 1,230 citations
Targeted cancer therapy
2004 • 1,116 citations
Isolation of cancer stem cells from adult glioblastoma multiforme
2004 • 788 citations
Gene Expression Profiling of Gliomas Strongly Predicts Survival
2004 • 732 citations
Phase II Trial of Gefitinib in Recurrent Glioblastoma
2003 • 730 citations
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
2001 • 708 citations
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
2005 • 499 citations
Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib
2005 • 468 citations
PDGF receptors as cancer drug targets
2003 • 462 citations
Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme
2005 • 333 citations
PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma
2004 • 320 citations
Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.
1988 • 288 citations
Identification of molecular subtypes of glioblastoma by gene expression profiling
2003 • 275 citations
KIT and Platelet-Derived Growth Factor Receptor Alpha Tyrosine Kinase Gene Mutations and KIT Amplifications in Human Solid Tumors
2004 • 201 citations
Platelet‐derived growth factor in human glioma
1995 • 196 citations
Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series
2005 • 176 citations
Stromal cell-derived factor-1α (SDF-1α/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation
2005 • 161 citations
CXCL-12/Stromal Cell–Derived Factor-1α Transactivates HER2-neu in Breast Cancer Cells by a Novel Pathway Involving Src Kinase Activation
2005 • 157 citations
Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells.
1993 • 155 citations
Epidermal Growth Factor Receptor Mutations in Patients with Non–Small Cell Lung Cancer
2005 • 146 citations
Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor.
1994 • 116 citations